LRRC15 at the Crossroads: Radioimmunotherapy Charts a Potential Path Forward

Leucine-rich repeat–containing protein 15 (LRRC15) is a cell surface protein that has emerged as a significant biomarker in cancer biology. This protein is minimally expressed in normal healthy tissues but becomes prominently upregulated in response to transforming growth factor-β (TGFβ)

Authors

Oliver Sartor

Institutions

Tulane University (US)
Louisiana State Department of Health and Hospitals (US)

Publication Details

Journal: Journal of Nuclear Medicine
Published: 2025-11-06
DOI: https://doi.org/10.2967/jnumed.125.271396
Primary Topic: Radiopharmaceutical Chemistry and Applications
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

LRRC15 at the Crossroads: Radioimmunotherapy Charts a Potential Path Forward

Oliver Sartor

Nov 6, 2025

Journal of Nuclear Medicine

Radiopharmaceutical Chemistry and Applications

article

LRRC15 at the Crossroads: Radioimmunotherapy Charts a Potential Path Forward

Oliver Sartor

November 6, 2025article en

Abstract

Journal of Nuclear MedicineVol. 67(2)

Tulane University (US), Louisiana State Department of Health and Hospitals (US)

Openalex Percentile: Top 52%

Radiopharmaceutical Chemistry and Applications

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

LRRC15 at the Crossroads: Radioimmunotherapy Charts a Potential Path Forward — Oliver Sartor · Journal of Nuclear Medicine (2025) | TGRS Research Map | TGRS